According to the latest disclosures from the Hong Kong Stock Exchange, FMR LLC increased its holdings in GENSCRIPT BIO (01548) by 6.846 million shares on September 24.
The shares were purchased at HK$40.2549 each, for a total consideration of approximately HK$276 million.
Following the increase, FMR LLC's latest holding stands at approximately 120 million shares, representing a 5.26% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.